KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
Want to see KALV full AI Analyst Report?
KalVista Pharmaceuticals (KALV) Ownership Overview
11.70% Insiders
14.27% Mutual Funds
0.20% Other Institutional Investors
12.07% ETFs
61.76% Public Companies and
Individual Investors
The ownership structure of KalVista Pharmaceuticals (KALV) stock is a mix of institutional, retail, and individual investors. Approximately 26.54% of the company’s stock is owned by Institutional Investors, 11.70% is owned by Insiders, and 61.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 27, 2026 | xxxxxxxxxxxxx | $3691148 | |
Jul 10, 2025 | xxxxxxxxxxxxx | $474623 | |
Jul 10, 2025 | xxxxxxxxxxxxx | $517441 | |
Apr 11, 2025 | xxxxxxxxxxxxx | $235500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $31025636 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,089,354 | Insider | 9.94% | 135,631,284 | |
| 2,808,583 | Institution | 5.48% | 74,848,737 | |
| 2,105,374 | Institution | 4.11% | 56,108,217 | |
| 1,921,092 | Institution | 3.75% | 51,197,102 | |
| 1,810,090 | Institution | 3.53% | 48,238,899 | |
| 1,777,827 | Institution | 3.47% | 47,379,090 | |
| 1,281,907 | Institution | 2.50% | 34,162,822 | |
| 462,577 | Insider | 0.90% | 12,327,677 | |
| 404,954 | Institution | 0.79% | 10,792,024 | |
| 404,622 | Institution | 0.79% | 10,783,176 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,808,583 | Institution | 5.48% | 74,848,737 | |
| 1,777,827 | Institution | 3.47% | 47,379,090 | |
| 404,954 | Institution | 0.79% | 10,792,024 | |
| 404,622 | Institution | 0.79% | 10,783,176 | |
| 322,565 | Institution | 0.63% | 8,596,357 | |
| 300,117 | Institution | 0.59% | 7,998,118 | |
| 228,410 | Institution | 0.45% | 6,087,127 | |
| 212,587 | Institution | 0.42% | 5,665,444 | |
| 123,235 | Institution | 0.24% | 3,284,213 | |
| 115,851 | Institution | 0.23% | 3,087,429 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,349,851 | Institution | 2.64% | 27,172,501 | |
| 1,201,543 | Institution | 2.35% | 32,033,136 | |
| 905,839 | Institution | 1.77% | 24,140,609 | |
| 439,731 | Institution | 0.86% | 8,851,785 | |
| 313,957 | Institution | 0.61% | 8,366,954 | |
| 275,802 | Institution | 0.54% | 7,350,123 | |
| 226,991 | Institution | 0.44% | 6,051,580 | |
| 189,568 | Institution | 0.37% | 5,053,883 | |
| 188,805 | Institution | 0.37% | 3,800,645 | |
| 151,145 | Institution | 0.30% | 4,029,526 |
FAQ
Who Owns KalVista Pharmaceuticals (KALV)?
According to the latest TipRanks data, approximately 0.20% of the company's stock is held by institutional investors, 11.70% is held by insiders, and 61.76% is held by retail investors.
What percentage of KalVista Pharmaceuticals (KALV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.20% of KalVista Pharmaceuticals (KALV) stock is held by institutional investors.
What percentage of KalVista Pharmaceuticals (KALV) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.76% of KalVista Pharmaceuticals (KALV) stock is held by retail investors.
Who owns the most shares of KalVista Pharmaceuticals (KALV)?
Venrock Healthcare Capital Partners III, L.P. owns the most shares of KalVista Pharmaceuticals (KALV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.